TrialInvestigational new drugs2023

A phase 1 open-label study to assess the relative bioavailability of TAK-931 tablets in reference to powder-in-capsule in patients with advanced solid tumors.

Neeltje Steeghs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.